First-line therapy for both topical and systemic mycosis includes azoles. Despite their widespread use, they rarely cause cutaneous allergic reactions.1 We present a patient with allergic contact dermati- tis localized on the feet and around the toenails, who experienced a generalized cutaneous reaction secondary to oral fluconazole, in whom a prompter dermatological visit would have anticipated the cor- rect diagnosis.
Bruni F., Di Altobrando A., Alessandrini A., Starace M., Piraccini B.M., Vincenzi C. (2021). Delayed access and provision of dermatological care as a collateral damage of COVID-19-related fear: Allergic contact dermatitis to fluconazole. CONTACT DERMATITIS, 84(5), 354-356 [10.1111/cod.13748].
Delayed access and provision of dermatological care as a collateral damage of COVID-19-related fear: Allergic contact dermatitis to fluconazole
Di Altobrando A.;Alessandrini A.;Starace M.;Piraccini B. M.;
2021
Abstract
First-line therapy for both topical and systemic mycosis includes azoles. Despite their widespread use, they rarely cause cutaneous allergic reactions.1 We present a patient with allergic contact dermati- tis localized on the feet and around the toenails, who experienced a generalized cutaneous reaction secondary to oral fluconazole, in whom a prompter dermatological visit would have anticipated the cor- rect diagnosis.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.